These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33580599)

  • 21. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.
    Dong F; Wang C; Farris AB; Wu S; Lee H; Olumi AF; McDougal WS; Young RH; Wu CL
    Am J Surg Pathol; 2012 Jun; 36(6):838-43. PubMed ID: 22592143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
    Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
    Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of the International Society of Urological Pathology modified Gleason grading system.
    Egevad L; Mazzucchelli R; Montironi R
    Arch Pathol Lab Med; 2012 Apr; 136(4):426-34. PubMed ID: 22458905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
    van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA
    Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
    Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
    BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer with tertiary Gleason pattern 5 in prostate needle biopsy: clinicopathologic findings and disease progression.
    Trpkov K; Zhang J; Chan M; Eigl BJ; Yilmaz A
    Am J Surg Pathol; 2009 Feb; 33(2):233-40. PubMed ID: 18936690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.
    Harnden P; Shelley MD; Coles B; Staffurth J; Mason MD
    Lancet Oncol; 2007 May; 8(5):411-9. PubMed ID: 17466898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer.
    Doshi C; Vacchio M; Attwood K; Murekeyisoni C; Mehedint DC; Badkhshan S; Azabdaftari G; Sule N; Guru KA; Mohler JL; Kauffman EC
    Prostate; 2016 Jun; 76(8):715-21. PubMed ID: 26880312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Narrative review of prostate cancer grading systems: will the Gleason scores be replaced by the Grade Groups?
    Montironi R; Cheng L; Cimadamore A; Mazzucchelli R; Scarpelli M; Santoni M; Massari F; Lopez-Beltran A
    Transl Androl Urol; 2021 Mar; 10(3):1530-1540. PubMed ID: 33850787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gleason grading: past, present and future.
    Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
    Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy.
    Adam M; Hannah A; Budäus L; Steuber T; Salomon G; Michl U; Haese A; Fisch M; Wittmer C; Steurer S; Minner S; Heinzer H; Huland H; Graefen M; Sauter G; Schlomm T; Isbarn H
    J Urol; 2014 Jul; 192(1):97-101. PubMed ID: 24518778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
    Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
    Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary Gleason grading and novel Grade Groups in clinical practice.
    Magi-Galluzzi C; Montironi R; Epstein JI
    Curr Opin Urol; 2016 Sep; 26(5):488-92. PubMed ID: 27308734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer.
    Sharma M; Miyamoto H
    Transl Androl Urol; 2018 Sep; 7(Suppl 4):S484-S489. PubMed ID: 30363387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
    Epstein JI; Amin MB; Fine SW; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong Q; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Trpkov K
    Arch Pathol Lab Med; 2021 Apr; 145(4):461-493. PubMed ID: 32589068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.
    Patel AA; Chen MH; Renshaw AA; D'Amico AV
    JAMA; 2007 Oct; 298(13):1533-8. PubMed ID: 17911498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups.
    Offermann A; Hohensteiner S; Kuempers C; Ribbat-Idel J; Schneider F; Becker F; Hupe MC; Duensing S; Merseburger AS; Kirfel J; Reischl M; Lubczyk V; Kuefer R; Perner S
    Front Med (Lausanne); 2017; 4():157. PubMed ID: 29034236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.
    Kır G; Seneldir H; Gumus E
    Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.